This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
A final total of 3,373 children with at least one major key item or at least two minor key items were entered into the study. Children were initially stratified into age bands of 1-4, 5-9 and 10-15 inclusive. By a system of random generation the children were entered into the intervention group (n = 1585) and the control group (n = 1563). A total of 351 patients in the intervention group defaulted assessment in year 2 and 291 patients were not formally assessed (reason not stated). Power calculations in determining the sample size were not stated.
Study design
Randomised controlled trial (stratified) over 12 GP practice sites. The method of randomisation was not explicitly stated. Stratification according to age group was carried out and clinicians were blinded from the control group. A loss to follow-up of 6.7% occurred due to patients leaving the practices over the period of the study, and 5 more patients were excluded as they had confounding symptoms from other conditions (cystic fibrosis and Down's syndrome). The period of follow-up was 12 months.
Analysis of effectiveness
The analysis investigated intention to treat. Health outcomes were measured in terms of asthma-related consultations, prescriptions and hospital attendances.
Effectiveness results
In comparison with the controls, the intervention group had:
(1) more practice initiated consultations for asthma (relative risk 2.18 (95% CI 1.74 to 2.73)) (2) more new diagnoses of asthma (relative risk 2.83 (95% CI 2.26 to 3.54)) (3) more past diagnoses reaffirmed (relative risk 1.3 (95% CI 1.08 to 1.58)) (4) were prescribed inhaled cromoglycate more frequently (relative risk 1.52 (95 % CI 1.02 to 2.25)).
Hospital inpatient day rates fell from 152 to 122 in the intervention group and rose from 69 to 117 in the control group between the year before and the year after the study.
Clinical conclusions
An audit facilitator can bring about a favourable influence in the pattern of diagnosis and treatment of childhood asthma in general practice.
Measure of benefits used in the economic analysis
Intermediate outcomes were measured in terms of asthma related consultations, prescriptions and hospital attendances.
Direct costs
Some costs and quantities were reported separately. Direct costs included:
GP consultation or day-time visit, review, nurse review, out-of-hours visit, night visit,
